167 related articles for article (PubMed ID: 23508981)
1. Association of gankyrin and stemness factor expression in human colorectal cancer.
Mine H; Sakurai T; Kashida H; Matsui S; Nishida N; Nagai T; Hagiwara S; Watanabe T; Kudo M
Dig Dis Sci; 2013 Aug; 58(8):2337-44. PubMed ID: 23508981
[TBL] [Abstract][Full Text] [Related]
2. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
[TBL] [Abstract][Full Text] [Related]
3. Gankyrin activates mTORC1 signaling by accelerating TSC2 degradation in colorectal cancer.
Qin X; Wang X; Liu F; Morris LE; Wang X; Jiang B; Zhang Y
Cancer Lett; 2016 Jun; 376(1):83-94. PubMed ID: 26975632
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of CDH1 is associated with expression of SNAI1 in colorectal adenomas.
Kroepil F; Fluegen G; Totikov Z; Baldus SE; Vay C; Schauer M; Topp SA; Esch JS; Knoefel WT; Stoecklein NH
PLoS One; 2012; 7(9):e46665. PubMed ID: 23029563
[TBL] [Abstract][Full Text] [Related]
5. Gankyrin Contributes to Tumorigenesis and Chemoresistance in Sporadic Colorectal Cancer.
Sakurai T; Komeda Y; Nagai T; Kamata K; Minaga K; Yamao K; Takenaka M; Hagiwara S; Watanabe T; Nishida N; Kashida H; Nakagawa K; Kudo M
Digestion; 2019; 100(3):192-200. PubMed ID: 30513515
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer.
Tang S; Yang G; Meng Y; Du R; Li X; Fan R; Zhao L; Bi Q; Jin J; Gao L; Zhang L; Li H; Fan M; Wang Y; Wu K; Liu J; Fan D
Cancer Biol Ther; 2010 Jan; 9(2):88-95. PubMed ID: 19901563
[TBL] [Abstract][Full Text] [Related]
7. Nanog: a potential biomarker for liver metastasis of colorectal cancer.
Xu F; Dai C; Zhang R; Zhao Y; Peng S; Jia C
Dig Dis Sci; 2012 Sep; 57(9):2340-6. PubMed ID: 22562535
[TBL] [Abstract][Full Text] [Related]
8. The oncoprotein gankyrin promotes the development of colitis-associated cancer through activation of STAT3.
Sakurai T; Higashitsuji H; Kashida H; Watanabe T; Komeda Y; Nagai T; Hagiwara S; Kitano M; Nishida N; Abe T; Kiyonari H; Itoh K; Fujita J; Kudo M
Oncotarget; 2017 Apr; 8(15):24762-24776. PubMed ID: 28160571
[TBL] [Abstract][Full Text] [Related]
9. Gankyrin activates IL-8 to promote hepatic metastasis of colorectal cancer.
Bai Z; Tai Y; Li W; Zhen C; Gu W; Jian Z; Wang Q; Lin JE; Zhao Q; Gong W; Liang B; Wang C; Zhou T
Cancer Res; 2013 Jul; 73(14):4548-58. PubMed ID: 23576566
[TBL] [Abstract][Full Text] [Related]
10. BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells.
Sarkar D; Shields B; Davies ML; Müller J; Wakeman JA
Int J Cancer; 2012 Jan; 130(2):328-37. PubMed ID: 21365650
[TBL] [Abstract][Full Text] [Related]
11. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
12. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
13. The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.
Wangpu X; Yang X; Zhao J; Lu J; Guan S; Lu J; Kovacevic Z; Liu W; Mi L; Jin R; Sun J; Yue F; Ma J; Lu A; Richardson DR; Wang L; Zheng M
Oncotarget; 2015 Oct; 6(32):33893-911. PubMed ID: 26418878
[TBL] [Abstract][Full Text] [Related]
14. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
[TBL] [Abstract][Full Text] [Related]
15. The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer.
Elsaba TM; Martinez-Pomares L; Robins AR; Crook S; Seth R; Jackson D; McCart A; Silver AR; Tomlinson IP; Ilyas M
PLoS One; 2010 May; 5(5):e10714. PubMed ID: 20502714
[TBL] [Abstract][Full Text] [Related]
16. Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer.
Jiang Y; Iakova P; Jin J; Sullivan E; Sharin V; Hong IH; Anakk S; Mayor A; Darlington G; Finegold M; Moore D; Timchenko NA
Hepatology; 2013 Mar; 57(3):1098-106. PubMed ID: 23172628
[TBL] [Abstract][Full Text] [Related]
17. Biological significance of tumor budding at the invasive front of human colorectal carcinoma cells.
Yusra ; Semba S; Yokozaki H
Int J Oncol; 2012 Jul; 41(1):201-10. PubMed ID: 22569829
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic analysis reveals the underlying pro-malignant functions of Gankyrin for colorectal cancer via affecting tumor necrosis factor pathway.
Xu B; Li S; Lv W; Wang Y; Li X; Zhang L; Lin J
Int J Biol Macromol; 2018 Oct; 117():1011-1016. PubMed ID: 29883699
[TBL] [Abstract][Full Text] [Related]
19. Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma.
Sakurai T; Yada N; Hagiwara S; Arizumi T; Minaga K; Kamata K; Takenaka M; Minami Y; Watanabe T; Nishida N; Kudo M
Cancer Sci; 2017 Oct; 108(10):1996-2003. PubMed ID: 28777492
[TBL] [Abstract][Full Text] [Related]
20. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
